4.7 Review

Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile

Journal

GUT MICROBES
Volume 13, Issue 1, Pages -

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/19490976.2021.1979882

Keywords

Dysbiosis; toxins; inflammasome; pseudomembranous colitis; inflammatory bowel disease; innate lymphoid cells

Funding

  1. BSR Start-Up Research Grant (UGC India)
  2. National Institutes of Health grants [R01-AI132711, R01-AI149852]
  3. Lab Infrastructure grant by BHU, Varanasi F(C)/XVIII-Spl.Fund/Misc/Infrastructure/Instt [Sc/2019-2020/10290]
  4. BTISNET-Sub-Distributed Information Centre - DBT, Govt. of India at the School of Biotechnology, Banaras Hindu University, Varanasi, India
  5. Department of Science and Technology, New Delhi, Govt. of India, through FIST grants [1196 SR/FST/LSI/2017/4]

Ask authors/readers for more resources

Pathobionts are opportunistic microbes that emerge as a result of perturbations in the healthy microbiome due to complex interactions of various genetic, exposomal, microbial, and host factors, leading to their proliferation, which may exacerbate inflammation, trigger autoimmune diseases, and even lead to life-threatening conditions. The current surge in microbiome research is unraveling the complex interplays between disease development and protection against pathobionts.
Pathobionts are opportunistic microbes that emerge as a result of perturbations in the healthy microbiome due to complex interactions of various genetic, exposomal, microbial, and host factors that lead to their selection and expansion. Their proliferations can aggravate inflammatory manifestations, trigger autoimmune diseases, and lead to severe life-threatening conditions. Current surge in microbiome research is unwinding these complex interplays between disease development and protection against pathobionts. This review summarizes the current knowledge of pathobiont emergence with a focus on Clostridioides difficile and the recent findings on the roles of immune cells such as iTreg cells, Th17 cells, innate lymphoid cells, and cytokines in protection against pathobionts. The review calls for adoption of innovative tools and cutting-edge technologies in clinical diagnostics and therapeutics to provide insights in identification and quantification of pathobionts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available